Related Experiment Video
Updated: May 13, 2026

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry
Published on: March 24, 2023
Proteasomal regulation of caspase-8 in cancer cell apoptosis
Michael V Fiandalo1, Steven R Schwarze, Natasha Kyprianou
1Department of Molecular and Cellular Biochemistry and the Markey Cancer Center, University of Kentucky College of Medicine, Combs Cancer Research Building, 306, 800 Rose Street, Lexington, KY 40536, USA.
Abstract:
Previous studies demonstrated that proteasome inhibition sensitizes TRAIL resistant prostate cancer cells to TRAIL-mediated apoptosis via stabilization of the active p18 subunit of caspase-8. The present study investigated the impact of proteasome inhibition on caspase-8 stability, ubiquitination, trafficking, and activation in cancer cells. Using caspase-8 deficient neuroblastoma (NB7) cells for reconstituting non-cleavable mutant forms of caspase-8, we demonstrated that the non-cleavable forms of caspase-8 are capable of inducing apoptosis comparably to wild-type caspase-8, in response to proteasome inhibitor and GST-TRAIL. Moreover in the LNCaP human prostate cancer cells, caspase-8 polyubiquitination occurs after TRAIL stimulation and caspase-8 processing. Subcellular fractionation analysis revealed caspase-8 activity in both cytosol and plasma membrane fractions in both NB7 reconstituted caspase-8 cell lines, as well the LNCaP prostate cancer cells. The present results suggest that caspase-8 stabilization through proteasome inhibition leads to reactivation of the extrinsic pathway of apoptosis and identify E3 ligase mediating caspase-8 polyubiquitination, as a novel molecular target. Inhibition of this E3 ligase in combination with TRAIL towards restoring apoptosis signaling activation may have potential therapeutic significance in resistant tumors.
Insights
Proteasome inhibition reactivates apoptosis in TRAIL-resistant prostate cancer by stabilizing caspase-8. Targeting the E3 ligase involved in caspase-8 polyubiquitination offers a new therapeutic strategy for resistant tumors.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Death Signaling
Background:
- Proteasome inhibition enhances TRAIL-induced apoptosis in resistant prostate cancer by stabilizing caspase-8.
- The precise mechanisms of caspase-8 regulation, including its stability, ubiquitination, and trafficking, remain incompletely understood in the context of proteasome inhibition and TRAIL resistance.
Purpose of the Study:
- To investigate the role of proteasome inhibition in caspase-8 stability, ubiquitination, trafficking, and activation in cancer cells.
- To explore the therapeutic potential of targeting caspase-8 regulation in TRAIL-resistant cancers.
Main Methods:
- Utilized caspase-8 deficient neuroblastoma (NB7) cells reconstituted with non-cleavable caspase-8 mutants.
- Employed GST-TRAIL and proteasome inhibitors for apoptosis induction.
- Performed subcellular fractionation to analyze caspase-8 activity.
- Investigated caspase-8 polyubiquitination in LNCaP human prostate cancer cells.
Main Results:
- Non-cleavable caspase-8 mutants induced apoptosis similarly to wild-type caspase-8 upon proteasome inhibition and GST-TRAIL treatment.
- Caspase-8 polyubiquitination was observed after TRAIL stimulation and processing in LNCaP cells.
- Caspase-8 activity was detected in both cytosolic and plasma membrane fractions.
Conclusions:
- Proteasome inhibition stabilizes caspase-8, reactivating the extrinsic apoptosis pathway in resistant cancer cells.
- Identifying the E3 ligase responsible for caspase-8 polyubiquitination presents a novel therapeutic target.
- Combined inhibition of this E3 ligase with TRAIL may restore apoptosis signaling in resistant tumors, holding therapeutic significance.
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Extrinsic Apoptotic Pathway
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

